$1 Billion Supports Vaccine Manufacturing in Africa Precision Vaccinations News – Precision Vaccinations

(Precision Vaccinations News)

The Africa Centres for Disease Control and Prevention (Africa CDC) recently welcomed the announcement from The Global Vaccine Alliance (GAVI) Board for the establishment of the African Vaccine Manufacturing Accelerator (AVMA).

The AVMA is a financing mechanism to create a sustainable vaccine manufacturing industry in Africa. It will make up to $1 billion in funds available to support vaccine manufacturing in Africa.

Dr. Jean Kaseya, Africa CDC Director General, commented in a press release on December 8, 2023,"Today is a significant moment for Africa. The targeted USD 1 Billion from GAVI to African Manufacturers is a game changer for the continent and advances our efforts towards vaccine self-reliance."

"The African Union has set a target for the continent to produce 60% of the vaccines needed by 2040, and theAVMA is indeed an accelerator towards that ambition."

"GAVI has been an incredible partner in this; we will continue to advance together on this journey of self-reliance. Together, we are united with a mission for vaccine equity."

The launch of AVMA is an important message from our partners that Africa will no longer be solely a recipient of vaccines but an active member and contributor to the global vaccine ecosystem.

The collaboration has seen several vaccine manufacturing projects taking shape, and others are in the works to guarantee self-reliance in Africa should any health emergency or outbreak hit the continent.

In addition, Africa CDC remains committed to collaborating with all partners and stakeholders in the vaccine ecosystem to facilitate the full operationalization of AVMA and expedite the attainment of health security, as envisaged in Agenda 2063.

Go here to read the rest:

$1 Billion Supports Vaccine Manufacturing in Africa Precision Vaccinations News - Precision Vaccinations